🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › Alabama › Birmingham

Etid klinik pou Kansè renn (Kasinom selil renn) nan Birmingham, AL

7 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Ap rekriteFaz 1
  • Research Site, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05536141

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon
  • Research Site, Birmingham
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

Ap rekriteFaz 2
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Oct 21, 2025 · NCT06005818

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Ap rekriteFaz 3
  • University of Alabama at Birmingham Cancer Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.